Archive: 12/02/2016

Cold-Eeze CEO speaks about firm's new male sex drive pill

Don't bother trying to tease Theodore Karkus, the chief executive of ProPhase Labs Inc., about his Philadelphia-area company's new product, a male enhancement dietary supplement, Legendz XL.

Feb 12, 2016

Dexamethasone no help in HIV-linked cryptococcal meningitis

(HealthDay)—For patients with HIV-associated cryptococcal meningitis, dexamethasone does not reduce mortality compared with placebo, according to a study published in the Feb. 11 issue of the New England Journal of Medicine.

Feb 12, 2016

0

46

Rate of missed adenomas >5 mm similarly low for BBPS 2, 3

(HealthDay)—The rate of missed adenomas larger than 5 mm is similarly low for men with Boston Bowel Prep Scale (BBPS) scores of 2 or 3, according to a study published in the February issue of Gastroenterology.

Feb 12, 2016

0

35

Vignette highlights management of recurrent UTI in older men

(HealthDay)—In a case vignette published in the Feb. 11 issue of the New England Journal of Medicine, recommendations are presented for management of recurrent acute febrile urinary tract infections in older men.

Feb 12, 2016

0

27

Valentine's Day can still be sweet for loved ones with diabetes

(HealthDay)—If your sweetheart has diabetes or prediabetes, get creative and celebrate Valentine's Day without chocolates or a fancy restaurant meal, an expert says.

Feb 12, 2016

0

132

Durable response with insulin pump therapy in T2DM

(HealthDay)—Insulin pump therapy is more effective than multiple daily injections (MDI) for glycemic control in patients with type 2 diabetes, according to a study published online Feb. 8 in Diabetes, Obesity and Metabolism.

Feb 12, 2016

0

142

Same-day discharge OK for minimally invasive myomectomy

(HealthDay)—Discharging patients on the same day following a minimally invasive myomectomy appears to be a safe option, according to research published in the March issue of Obstetrics & Gynecology.

Feb 12, 2016

0

29

Sedatives appear to be safe in alcohol withdrawal syndrome

(HealthDay)—For patients with alcohol withdrawal syndrome, treatment with high-dose intravenous sedatives is not associated with excess morbidity or mortality, according to a study published in the February issue of the American ...

Feb 12, 2016